MedTrace Logo

14729-D9831C00002- 1 Month Biopsy Study

NCT00766415 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2014-02-28

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to study histological changes, cellularity, clinical efficacy and safety of AZD1981 in patients with Chronic Obstructive Pulmonary Disease

Conditions

Interventions

DRUG

AZD1981

Oral tablet, twice daily, 4 weeks treatment

DRUG

Placebo

Placebo

Sponsors & Collaborators

Principal Investigators

  • Norbert Krug · Fraunhofer Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Completion
2009-06-30

Countries

  • Germany
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00766415 on ClinicalTrials.gov